NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Languages English Remove constraint Languages: English Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

2607. State-funded home and community-based services programs for older adults

2608. Recognizing destabilization in the individual health insurance market

2609. Weathering the storm: the impact of the Great Recession on long-term services and supports

2610. Employers' use of health insurance exchanges: lessons from Massachusetts

2611. Medicare's value-based, physician payment modifier: improving the quality and efficiency of medical care

2614. Social Security: a lifeline for older women and minorities

2615. Breaking through the noise: the facts about the Medicaid program

2619. Reducing potential overuse of dementia drugs could lead to considerable savings

2622. Taking it to the next level: using innovative strategies to expand options for self-direction

2623. State flexibility in a new era: what are the research priorities for Section 1115 demonstrations?

2625. California's ambulatory surgery centers: a black box of care

2626. Short-term, limited-duration insurance and risks to California's insurance market

2630. California employer health benefits: workers shoulder more costs

2631. Ensuring health plan mergers benefit the community: California regulators and infrastructure investment programs

2632. California's uninsured: progress toward universal coverage

2633. California emergency departments: use grows as coverage expands

2634. Financing community health workers in transitions clinics

2635. MAT in community health centers

2636. Preventing unintended pregnancy in Mississippi

2637. Health insurance coverage and the ACA: knowledge, attitudes, and behaviors of Mississippi adults

2639. Long-acting reversible contraceptives: a survey of Mississippi health care providers

2640. Mississippi Medicaid tobacco-related cost

2641. How could the public charge proposed rule affect community health centers?

2642. Top spenders among commercially-insured: increased spending concentration and consistent turnover from 2013 to 2015

2643. Under pressure: adults with hypertension are spending increasingly more on health care

2644. The rising cost of specialty drugs drove spending increases for people with multiple sclerosis

2645. Trends in primary care visits

2646. Spending on individuals with type 1 diabetes and the role of rapidly increasing insulin prices

2647. Why becoming a good parent begins in infancy: how relationship skills are developed throughout the life course

2648. Aligning services with needs: characterizing the pyramid of complexity tiering for children with chronic and complex conditions

2649. How California Children’s Services Programs in the 21 Whole-Child Model counties engage with families

2651. Threading the labyrinth: why children in California with special health care needs endure delays in securing the medical equipment and supplies they need

2652. A better way: team care for children with special health care needs

2653. Achieving care integration for children with medical complexity: the human-centered design approach to care coordination

2656. Voretigene neparvovec for biallelic RPE65-mediated retinal disease: effectiveness and value : final evidence report

2657. Chimeric antigen receptor T-cell therapy for B-cell cancers: effectiveness and value : final evidence report

2658. Emicizumab for hemophilia A with inhibitors: effectiveness and value : final evidence report

2659. Modulator treatments for cystic fibrosis: effectiveness and value : final evidence report and meeting summary

2660. Calcitonin gene-related peptide (CGRP) inhibitors as preventive treatments for patients with episodic or chronic migraine: effectiveness and value : final evidence report

2661. Elagolix for treating endometriosis: final evidence report

2662. Targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: effectiveness and value : condition update : final evidence report

2663. Inotersen and patisiran for hereditary transthyretin amyloidosis: effectiveness and value : final evidence report

2664. Antiandrogen therapies for nonmetastatic castration-resistant prostate cancer: effectiveness and value : final evidence report

2665. Prophylaxis for hereditary angioedema with lanadelumab and C1 Inhibitors: effectiveness and value : final evidence report

2666. Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report

2667. Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report

2668. Assessment and synthesis of selected Medicaid eligibility, enrollment, and renewal processes and systems in six states

2669. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Arizona

2670. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Colorado

2671. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Florida

2672. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Idaho

2673. Medicaid eligibility, enrollment, and renewal processes and system study: case study summary report--New York

2674. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--North Carolina

2675. Leveraging 1332 state innovation waivers to stabilize individual health insurance markets: experiences of Alaska, Minnesota, and Oregon : final report : document efforts to stabilize the individual market using state-based reinsurance

2676. Imported seafood safety: FDA and USDA could strengthen efforts to prevent unsafe drug residues : report to the chairman, Committee on Appropriations, U.S. Senate

2677. Low-wage workers: poverty and use of selected federal social safety net programs persist among working families : report to the ranking member, Subcommittee on Primary Health and Retirement Security, Committee on Health, Education, Labor, and Pensions, U.S. Senate

2678. Climate change: information on potential economic effects could help guide federal efforts to reduce fiscal exposure : report to Congressional requesters

2679. Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate

2680. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters

2681. Federal employees health benefits program: enrollment remains concentrated despite more plan offerings, and effects of adding plan types are uncertain : report to the ranking member, Committee on Oversight and Government Reform, House of Representatives

2682. Counternarcotics: overview of U.S. efforts in the Western Hemisphere : report to the ranking member, Committee on Foreign Affairs, House of Representatives

2683. Preventing drug abuse: low participation by pharmacies and other entities as voluntary collectors of unused prescription drugs : report to Congressional requesters

2684. Low-dose radiation: interagency collaboration on planning research could improve information on health effects : testimony before the Subcommittee on Energy, Committee on Science, Space, and Technology, House of Representatives

2685. High-containment laboratories: coordinated efforts needed to further strengthen oversight of select agents : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

2686. Child well-being: key considerations for policymakers including the need for a federal cross-agency priority goal : a report to Congress

2689. VA health care: improved policies and oversight needed for reviewing and reporting providers for quality and safety concerns : report to the chairman, Committee on Veterans' Affairs, House of Representatives

2690. VA health care: improved oversight needed for reviewing and reporting providers for quality and safety concerns : testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives

2691. Private school choice: federal actions needed to ensure parents are notified about changes in rights for students with disabilities : report to Congressional requesters

2692. Veterans affairs contracting: improvements in buying medical and surgical supplies could yield cost savings and efficiency : report to the chairman, Committee on Veterans' Affairs, House of Representatives

2693. Health insurance exchanges: changes in benchmark plans and premiums and effects of automatic re-enrollment on consumers' costs : report to Congressional requesters

2694. Drug industry: profits, research and development spending, and merger and acquisition deals : report to Congressional requesters

2695. Medicare and Medicaid: CMS needs to fully align its antifraud efforts with the fraud risk framework : report to Congressional addressees

2696. Sexual violence: actions needed to improve DOD's efforts to address the continuum of unwanted sexual behaviors : report to the Committee on Armed Services, U.S. Senate

2697. Medicaid: further action needed to expedite use of national data for program oversight : report to Congressional requesters

2698. Social Security disability: additional measures and evaluation needed to enhance accuracy and consistency of hearings decisions : report to the Chairman, Subcommittee on Social Security, Committee on Ways and Means, House of Representatives

2699. FDA medical device reviews: evaluation is needed to assure requests for additional information follow a least burdensome approach : report to Congressional requestors

2700. Generic drugs: FDA should make public its plans to issue and revise guidance on nonbiological complex drugs : report to Congressional requesters